Deal-Making
SpliceBio deal adds extra ‘spark’ to Roche CGT ambitions
Deal MakingSpliceBio deal adds extra ‘spark’ to Roche CGT ambitionsSpliceBio deal adds extra ‘spark’ to Roche CGT ambitions
Roche subsidiary Spark will use SpliceBio's protein splicing platform to develop a gene therapy for an undisclosed inherited retinal disease.